HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Guido Kroemer Selected Research

Calreticulin

5/2013Immunological control of cell cycle aberrations for the avoidance of oncogenesis: the case of tetraploidy.
2/2013Immunosurveillance against tetraploidization-induced colon tumorigenesis.
9/2012An immunosurveillance mechanism controls cancer cell ploidy.
6/2010Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.
12/2009Disruption of the PP1/GADD34 complex induces calreticulin exposure.
9/2009Witch hunt against tumor cells enhanced by dendritic cells.
4/2009Immunogenic cell death modalities and their impact on cancer treatment.
2/2009Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals.
4/2008Immunogenicity of anthracyclines: moving towards more personalized medicine.
12/2007Ecto-calreticulin in immunogenic chemotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Guido Kroemer Research Topics

Disease

138Neoplasms (Cancer)
12/2015 - 03/2002
22Necrosis
11/2015 - 03/2004
14Tetraploidy
02/2014 - 06/2006
13Carcinoma (Carcinomatosis)
11/2014 - 01/2002
11Starvation
04/2015 - 11/2005
10Infection
09/2013 - 03/2002
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013 - 08/2004
9Breast Neoplasms (Breast Cancer)
10/2015 - 09/2007
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2014 - 02/2008
9Polyploidy
02/2014 - 09/2004
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2014 - 02/2006
7Neoplasm Metastasis (Metastasis)
11/2015 - 08/2011
7Anoxia (Hypoxia)
02/2013 - 07/2003
5Melanoma (Melanoma, Malignant)
11/2015 - 04/2006
4Colonic Neoplasms (Colon Cancer)
01/2015 - 04/2004
4Lung Neoplasms (Lung Cancer)
11/2014 - 03/2002
4Ischemia
10/2011 - 07/2003
3Obesity
01/2015 - 09/2011
3Neuroblastoma
11/2013 - 01/2002
3Inflammation
09/2013 - 10/2011
3Osteosarcoma (Osteogenic Sarcoma)
08/2013 - 03/2002
3Neurodegenerative Diseases (Neurodegenerative Disease)
05/2012 - 01/2007
3Residual Neoplasm
06/2010 - 10/2007
2Colorectal Neoplasms (Colorectal Cancer)
11/2015 - 08/2015
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
07/2014 - 10/2009
2Adenoma (Adenomas)
03/2014 - 09/2006
2Cystic Fibrosis (Mucoviscidosis)
01/2014 - 09/2013
2Atrophy
01/2014 - 12/2005
2Parkinson Disease (Parkinson's Disease)
11/2013 - 03/2008
2Glioblastoma (Glioblastoma Multiforme)
10/2013 - 03/2002
2Bacterial Infections (Bacterial Infection)
08/2013 - 03/2010
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2013 - 06/2011
2Rupture
03/2013 - 01/2007
2Leukemia
11/2012 - 01/2005

Drug/Important Bio-Agent (IBA)

20DNA (Deoxyribonucleic Acid)IBA
12/2015 - 05/2004
16Adenosine Triphosphate (ATP)IBA
10/2013 - 04/2004
15AnthracyclinesIBA
11/2015 - 09/2007
15AntigensIBA
12/2014 - 09/2007
14Proteins (Proteins, Gene)IBA
01/2015 - 05/2003
14CalreticulinIBA
05/2013 - 01/2007
13HMGB1 Protein (HMG1)IBA
10/2015 - 09/2007
13Cisplatin (Platino)FDA LinkGeneric
11/2014 - 04/2006
11Phosphotransferases (Kinase)IBA
02/2014 - 07/2008
8erlotinib (CP 358,774)FDA Link
12/2014 - 07/2007
8oxaliplatin (Eloxatin)FDA LinkGeneric
08/2013 - 09/2004
7Toll-Like Receptor 4IBA
08/2015 - 09/2007
7Apoptosis Inducing FactorIBA
01/2015 - 06/2003
6Epidermal Growth Factor Receptor (EGF Receptor)IBA
12/2014 - 07/2007
6Sirolimus (Rapamycin)FDA Link
10/2013 - 08/2006
5InterferonsIBA
09/2015 - 02/2006
5Transcription Factors (Transcription Factor)IBA
11/2014 - 03/2004
5CytokinesIBA
11/2014 - 01/2011
5InterleukinsIBA
11/2014 - 03/2010
5Neoplasm Antigens (Tumor Antigens)IBA
04/2013 - 12/2007
4ChromatinIBA
11/2015 - 09/2004
4Interleukin-18 (Interleukin 18)IBA
11/2014 - 08/2011
4gefitinib (Iressa)FDA Link
09/2013 - 12/2008
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2013 - 07/2007
4Purinergic Receptors (Receptors, Purine)IBA
04/2013 - 10/2009
4Cytochromes c (Cytochrome c)IBA
03/2013 - 06/2003
4CytotoxinsIBA
08/2012 - 12/2006
4LigandsIBA
07/2011 - 03/2002
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2010 - 04/2004
4Histones (Histone)IBA
03/2010 - 01/2008
4NF-kappa B (NF-kB)IBA
02/2006 - 03/2004
3Biological Markers (Surrogate Marker)IBA
05/2015 - 09/2011
3Carbon MonoxideIBA
12/2012 - 10/2004
3Caspase 3 (Caspase-3)IBA
03/2012 - 06/2003
3Retinaldehyde (Retinal)IBA
12/2011 - 03/2002
3Small Interfering RNA (siRNA)IBA
07/2010 - 03/2009
3Etoposide (VP 16)FDA LinkGeneric
01/2007 - 03/2002
2AntibodiesIBA
11/2015 - 05/2015
2ChemokinesIBA
09/2015 - 01/2010
2Purinergic P2X7 ReceptorsIBA
08/2015 - 06/2012
2Fatty Acids (Saturated Fatty Acids)IBA
04/2015 - 07/2010
2Protein Isoforms (Isoforms)IBA
04/2015 - 06/2011
2ipilimumabIBA
02/2015 - 09/2013
2Monoclonal AntibodiesIBA
12/2014 - 03/2014
2Azacitidine (5 Azacytidine)FDA Link
12/2014 - 11/2012
2Interleukin-12 (IL 12)IBA
11/2014 - 11/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
09/2014 - 10/2005
2resveratrolIBA
02/2014 - 10/2012
2CystamineIBA
01/2014 - 09/2013
2endonuclease GIBA
11/2013 - 05/2007
2Antineoplastic Agents (Antineoplastics)IBA
11/2013 - 07/2013
2XenobioticsIBA
09/2013 - 01/2007
2Pattern Recognition ReceptorsIBA
09/2013 - 08/2009
2imatinib (Gleevec)FDA Link
06/2013 - 03/2004
2Vitamin B 6IBA
02/2013 - 08/2012
2anthra(1,9-cd)pyrazol-6(2H)-oneIBA
01/2013 - 06/2012
2src-Family KinasesIBA
11/2012 - 09/2011
2N-acetylsphingosineIBA
09/2012 - 11/2011
2Protein-Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2012 - 09/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2011 - 02/2007

Therapy/Procedure

50Drug Therapy (Chemotherapy)
12/2015 - 12/2002
18Radiotherapy
08/2015 - 12/2006
5Immunotherapy
11/2015 - 01/2008
3Heterologous Transplantation (Xenotransplantation)
10/2013 - 07/2008
2Adjuvant Chemotherapy
11/2015 - 10/2015
2Caloric Restriction
01/2014 - 01/2010